Literature DB >> 11431377

Effect of changing tumor oxygenation on glycolytic metabolism in a murine C3H mammary carcinoma assessed by in vivo nuclear magnetic resonance spectroscopy.

F U Nielsen1, P Daugaard, L Bentzen, H Stødkilde-Jørgensen, J Overgaard, M R Horsman, R J Maxwell.   

Abstract

The rate of conversion of D-[1-(13)C]glucose into [3-(13)C]lactate (apparent glycolytic rate) has been determined in C3H murine mammary carcinomas in vivo using tumor-selective (13)C nuclear magnetic resonance spectroscopy with (1)H-(13)C cross-polarization. Under conditions of acute hypoxia induced by breathing carbon monoxide at 660 ppm, the apparent glycolytic rate was 0.0239 +/- 0.0019 min(-1). The proportion of (13)C label incorporated into [4-(13)C]glutamate (measured in tumor extracts) was 25-fold lower than that incorporated into [3-(13)C]lactate, reflecting a very limited oxidative metabolism during this hypoxic episode. For animals breathing air or carbogen (95% O(2) + 5% CO(2)), the calculated glycolytic rates were correspondingly lower (0.0160 +/- 0.0021 min(-1) and 0.0050 +/- 0.0011 min(-1), respectively). Although (13)C labeling of glutamate at C4 was still an order of magnitude lower than that for lactate at C3 (11-fold for air and 9-fold for carbogen), these ratios did show a greater degree of oxidative metabolism than that seen in animals breathing carbon monoxide at 660 ppm. The marked difference in apparent glycolytic rate for this tumor model between well-oxygenated and hypoxic conditions demonstrates a substantial Pasteur effect (inhibition of glycolysis by oxygen). Dynamic (13)C nuclear magnetic resonance spectroscopy provides a noninvasive estimate of tumor glycolysis that can be used to evaluate the relationship between oxygenation and energy metabolism, and this has potential consequences for the sensitivity of hypoxic cells to treatment and their ability to promote angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11431377

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  10 in total

1.  Fast volumetric spatial-spectral MR imaging of hyperpolarized 13C-labeled compounds using multiple echo 3D bSSFP.

Authors:  William H Perman; Pratip Bhattacharya; Jochen Leupold; Alexander P Lin; Kent C Harris; Valerie A Norton; Jan-Bernd Hövener; Brian D Ross
Journal:  Magn Reson Imaging       Date:  2010-02-18       Impact factor: 2.546

Review 2.  Magnetic resonance spectroscopy in metabolic and molecular imaging and diagnosis of cancer.

Authors:  Kristine Glunde; Dmitri Artemov; Marie-France Penet; Michael A Jacobs; Zaver M Bhujwalla
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

Review 3.  In vivo magnetic resonance spectroscopy of liver tumors and metastases.

Authors:  E G W ter Voert; L Heijmen; H W M van Laarhoven; A Heerschap
Journal:  World J Gastroenterol       Date:  2011-12-21       Impact factor: 5.742

Review 4.  Metabolic tumor imaging using magnetic resonance spectroscopy.

Authors:  Kristine Glunde; Zaver M Bhujwalla
Journal:  Semin Oncol       Date:  2011-02       Impact factor: 4.929

Review 5.  Hypoxic stress and cancer: imaging the axis of evil in tumor metastasis.

Authors:  Reut Avni; Batya Cohen; Michal Neeman
Journal:  NMR Biomed       Date:  2011-01-17       Impact factor: 4.044

6.  Molecular Imaging of Cancer: Applications of Magnetic Resonance Methods.

Authors:  Barjor Gimi; Arvind P Pathak; Ellen Ackerstaff; Kristine Glunde; Dmitri Artemov; Zaver M Bhujwalla
Journal:  Proc IEEE Inst Electr Electron Eng       Date:  2005-04-01       Impact factor: 10.961

7.  Combined MR, fluorescence and histology imaging strategy in a human breast tumor xenograft model.

Authors:  Lu Jiang; Tiffany R Greenwood; Erika R Amstalden van Hove; Kamila Chughtai; Venu Raman; Paul T Winnard; Ron M A Heeren; Dmitri Artemov; Kristine Glunde
Journal:  NMR Biomed       Date:  2012-09-04       Impact factor: 4.044

Review 8.  The Continuing Evolution of Molecular Functional Imaging in Clinical Oncology: The Road to Precision Medicine and Radiogenomics (Part II).

Authors:  Tanvi Vaidya; Archi Agrawal; Shivani Mahajan; M H Thakur; Abhishek Mahajan
Journal:  Mol Diagn Ther       Date:  2019-02       Impact factor: 4.074

9.  Measurement of the acute metabolic response to hypoxia in rat tumours in vivo using magnetic resonance spectroscopy and hyperpolarised pyruvate.

Authors:  Joanne E Bluff; Steven Reynolds; Stephen Metcalf; Tooba Alizadeh; Samira M Kazan; Adriana Bucur; Emily G Wholey; Becky A S Bibby; Leigh Williams; Martyn N Paley; Gillian M Tozer
Journal:  Radiother Oncol       Date:  2015-03-27       Impact factor: 6.280

Review 10.  Imaging metabolic heterogeneity in cancer.

Authors:  Debanti Sengupta; Guillem Pratx
Journal:  Mol Cancer       Date:  2016-01-06       Impact factor: 27.401

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.